Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Exosome Innovations: Pioneering Global Health with a CAGR of 42.2% (2023-2028)

BCC Research Logo

News provided by

BCC Research LLC

May 07, 2024, 05:22 ET

Share this article

Share toX

Share this article

Share toX

"Exosome Diagnostics, Therapeutics and Research Tools: Global Markets" is a detailed report that looks at how exosomes, which are tiny structures released by cells, are used in different ways worldwide. It talks about how they're used in diagnosing illnesses, making treatments, and doing research. BCC Research latest report talks about what's happening now, what might happen in the future, and any problems or opportunities that might come up.

BOSTON, May 7, 2024 /PRNewswire/ -- "According to the latest research study, the demand for Exosome Diagnostics, Therapeutics and Research Tools: Global Markets expected to grow from $227.5 million in 2023 and will reach $1.3 billion by the end of 2028 at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028"

This report is all about giving a thorough look at the worldwide market for exosome products used in diagnosing, treating, and researching medical conditions. It provides both numbers and descriptions to help readers plan their business strategies, understand the market, and make smart decisions about exosome-related products. The data covers the year 2022 and predicts values for the years 2023 to 2028.

It focuses on exosome products and research tools used in healthcare only. Anything related to exosomes in areas like skincare and beauty is not included in this report.

Some Interesting Facts

  • Currently, there are no officially approved treatments worldwide that use exosomes, whether they're in their natural form or modified.
  • Despite a lot of excitement about the potential for exosomes in medical tests and treatments, many new companies working in this area are having trouble getting enough money to keep going and do their research.

Click here to gain a deeper understanding of the complexities involved in Exosome Diagnostics, Therapeutics, and Research Tools within the global markets and explore further insights and details.

Exosome diagnostics, therapeutics, and research tools: global markets are driven by factors such as:

  1. Increasing Investment in Biomedical Research: More money is being spent on studying health issues and finding ways to fix them. This can mean creating new medicines, making better medical tools, or learning more about diseases to treat them. The goal is to use more resources to learn more about how to keep people healthy.
  2. Trend Towards Precision Medicine.: Precision medicine is when doctors make treatments that are just right for each person. They do this by learning about a person's genes, lifestyle, and where they live to pick the best treatment. It's like making a suit that fits perfectly instead of one that's the same for everyone.
  3. Technological Advancements in Exosome Research Tools.: Technological advancements in exosome research tools mean that scientists are finding better ways to study tiny cell structures called exosomes. These exosomes carry important messages and can affect different diseases. The improvements include better tools like powerful microscopes, more accurate ways to detect exosomes, and smarter computer programs to analyze the data. These upgrades help scientists learn more about exosomes and how they could be used to diagnose and treat diseases.

Request a Copy of the Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Report Synopsis        

Report Metrics

Details

Base year considered

2022

Forecast Period considered

2023-2028

Base year market size

$166.4 million

Market Size Forecast

$1.3 billion

Growth Rate

CAGR of 42.2% for the forecast period of 2023-2028

Segment Covered

By Application, By Region

Regions covered

North America, Europe, Asia-Pacific, Rest of the World (RoW)

Key Market Drivers

 

  • Increasing Investment in Biomedical Research
  • Trend Towards Precision Medicine
  • Technological Advancements in Exosome Research Tools

Segmentation Analysis 

The worldwide market for exosome tests, treatments, and tools is divided into different uses:

  • Diagnostics and Monitoring- means using exosomes to check for diseases or keep track of someone's health over time.
  • Treatments- refers to using exosomes to treat diseases or medical conditions.
  • Tools and Materials for Research- involves using exosomes in experiments or studies, and the equipment and substances needed for that research.

This report on exosome diagnostics, therapeutics, and research tools: global markets provide comprehensive insights and analysis, addressing the following key questions:

  1. What is the projected market size and growth rate of the exosome diagnostics, therapeutics, and research tools and reagents market?
    The global exosome diagnostics, therapeutics, and research tools and reagents market was estimated to be around $227.5 million in 2023. The market is projected to reach $1.3 billion in 2028, growing at a CAGR of 42.2% during the forecast period.

  2. What segments are covered in the market?
    An in-depth analysis of the global exosome diagnostics, therapeutics, and research tools and reagents market, including historical data and market projection on sales by application, and region.

  3. By application type, which segment will dominate the market by the end of 2028?
    By application type, diagnostics and monitoring segment is anticipated to dominate the market by the end of 2028.

  4. Which application type market is growing fastest among all?
    Diagnostics and monitoring is the fastest growing market.

Some of the Key Market Players Are:

  • ACOUSORT AB
  • AETHLON MEDICAL INC.
  • BIO-TECHNE
  • CARIS LIFE SCIENCES
  • EXOSOMICS SPA
  • KIMERA LABS
  • MIR SCIENTIFIC
  • NANOSOMIX
  • SYSTEM BIOSCIENCES LLC
  • AEGLE THERAPEUTICS
  • ARUNA BIO INC.
  • CAPRICOR THERAPEUTICS INC.
  • DIRECT BIOLOGICS LLC
  • EVOX THERAPEUTICS LTD.
  • LONZA
  • NANO MED
  • RION

Browse for more Related Reports:

Global Market for Cell and Gene Therapy: The global market for cell and gene therapy is all about making and selling treatments that use cells and genes to fix different illnesses. This includes researching, testing in hospitals, making the treatments, and selling them to help people get better or even cure them by using the body's own cells and genes.

Prevention and Treatment of Prostate Cancer: Technologies and Global Markets: This report is like a big book that talks about how doctors around the world are trying to stop and cure prostate cancer. It tells you about all the different ways they do this, like using new technologies and treatments. The book also talks about how the market for these treatments is growing and changing globally.

Directly Purchase a copy of the report with BCC Research.

For further information or to make a purchase, please get in touch with [email protected].  

About BCC Research

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts' goal is to help you make informed business decisions, free of noise and hype.

Contact Us
Corporate HQ: 50 Milk St. Ste 16, Boston, MA 02109, USA
Email: [email protected],
Phone: +1 781-489-7301
For media inquiries, email [email protected] or visit our media page for access to our market research library.

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

Logo: https://mma.prnewswire.com/media/2183242/BCC_Research_Logo.jpg

SOURCE BCC Research LLC

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Anesthesia and Respiratory Devices Market to Hit $74.8 Billion by 2030

Anesthesia and Respiratory Devices Market to Hit $74.8 Billion by 2030

According to the latest study from BCC Research, the "Anesthesia and Respiratory Devices: Global Markets" is expected to grow from $51.9 billion in...

AI Revolutionizes Food Safety and Quality Control Market, Projected to Grow at a CAGR of 30.9%

AI Revolutionizes Food Safety and Quality Control Market, Projected to Grow at a CAGR of 30.9%

According to the latest study from BCC Research, the "AI in Food Safety and Quality Control Market" is projected to reach $13.7 billion by 2030,...

More Releases From This Source

Explore

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

Biotechnology

Biotechnology

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.